Mark Egerton, PhD, chief executive officer of Quotient Sciences, shares insights on a new approach to accelerate drug development, which integrates formulation development, real-time adaptive GMP ...
Applying the right formulation strategies early in the drug development process can help avoid costly late-stage failures. Improving R&D productivity continues to be a key challenge for the ...
Researchers have used naïve pluripotent stem cells to create an embryo model that looks and acts like a natural human embryo. They say it’s an ethical way of gaining a better understanding of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback